Product image of Nasivara (Beclometasone Dipropionate) supplied by GNH India

Nasivara

Active Ingredient:
Beclometasone Dipropionate
Origin:
EU

Nasivara (Beclometasone Dipropionate)

Beclometasone dipropionate, the active ingredient in Nasivara, is a corticosteroid presented as a nasal spray for nasal administration. It is used to treat inflammatory nasal conditions such as allergic rhinitis and other nasal mucosal inflammations in adults and children. The molecule works locally in the nose to reduce swelling, itching and discharge, providing symptom relief without significant systemic exposure.

GNH India supplies Nasivara as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Ennogen Ip Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Nasivara is a nasal corticosteroid that acts on the inflammatory pathways of the nasal mucosa. It is indicated for:

  • Allergic rhinitis: reduces nasal congestion, sneezing, itching and rhinorrhea.
  • Seasonal or perennial nasal allergy: controls symptoms triggered by pollen, dust or animal dander.
  • Post‑operative nasal inflammation: helps maintain nasal patency after sinus surgery or polypectomy.

How It Works

  • Beclometasone dipropionate activates intracellular glucocorticoid receptors in nasal epithelial cells, leading to inhibition of pro‑inflammatory cytokine production, reduced vascular permeability and suppression of immune cell activation. This anti‑inflammatory cascade diminishes edema, mucus secretion and nasal hyper‑reactivity, providing local symptom control.

Side Effects

Common Side Effects

  • Nasal irritation or burning sensation.
  • Epistaxis (nosebleeds).
  • Headache.
  • Throat irritation or dryness.
  • Altered taste or unpleasant taste.
  • Cough.

Serious or Rare Side Effects

  • Fungal infection of the nasal mucosa.
  • Cataracts or glaucoma with prolonged use.
  • Adrenal suppression when used at high doses.
  • Severe or persistent nosebleeds.
  • Anaphylactic or severe allergic reaction.
  • Nasal septum perforation (very rare).

Precautions & Warnings

Before using Nasivara, consider the following precautions:

  • Assess infection risk: avoid use in active nasal or sinus infections unless directed by a clinician.
  • Monitor for ocular effects: advise patients to report visual changes that could indicate cataracts or glaucoma.
  • Evaluate systemic steroid exposure: limit concurrent high‑dose oral or injectable corticosteroids.
  • Use in pregnancy and lactation only if clearly needed and prescribed by a healthcare professional.
  • Pediatric use: follow pediatric dosing recommendations and monitor growth.
  • Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Beclometasone dipropionate may interact with other medicines as follows:

Major Interactions (Avoid)

  • Systemic corticosteroids: concurrent high‑dose oral or injectable steroids increase risk of adrenal suppression.
  • Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise systemic exposure of the nasal steroid.

Moderate Interactions (Monitor Closely)

  • Antifungal agents (e.g., fluconazole): may modestly increase systemic levels.
  • HIV protease inhibitors (e.g., ritonavir): require monitoring for systemic effects.
  • Nasal decongestants: combined use may increase local irritation.
  • Antihistamines: monitor for additive sedation if combined with sedating antihistamines.

Frequently Asked Questions

Nasivara is a nasal spray containing beclometasone dipropionate, a corticosteroid that reduces inflammation in the nasal passages. It is prescribed to relieve symptoms of allergic rhinitis, seasonal or perennial nasal allergies, and to manage post‑operative nasal inflammation.

Beclometasone dipropionate binds to glucocorticoid receptors in nasal epithelial cells, suppressing the release of inflammatory mediators such as cytokines and prostaglandins. This action decreases swelling, mucus production, and irritation, providing local symptom relief.

The specific dosing regimen for Nasivara is determined by the prescribing clinician based on the patient’s age, severity of symptoms, and treatment goals. Patients should follow the healthcare professional’s instructions and not adjust the dose on their own.

Safety in pregnancy and lactation has not been fully established. Use of Nasivara during pregnancy or while breastfeeding should only occur if the potential benefit justifies any potential risk and after consultation with a qualified healthcare provider.

To request Nasivara, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nasivara (beclometasone dipropionate) offers potent local anti‑inflammatory activity with a low systemic absorption profile, similar to other nasal corticosteroids such as fluticasone or mometasone. Choice among them often depends on physician preference, patient response, dosing frequency and formulary considerations.

Nasivara should be stored at ambient temperature, preferably below 25 °C. Keep the spray in its original container, protect it from moisture and direct sunlight, and ensure the cap is tightly closed when not in use.

Nasivara is administered as a nasal spray. The patient gently tilts the head forward, inserts the nozzle into one nostril, and sprays the prescribed number of sprays while breathing in gently. The process is repeated in the other nostril if directed by the prescriber.

Serious risks, though rare, include fungal infection of the nasal mucosa, cataracts or glaucoma with long‑term use, adrenal suppression when combined with systemic steroids, and severe allergic reactions such as anaphylaxis. Patients should report any unusual symptoms promptly.

Nasivara should be avoided in individuals with known hypersensitivity to beclometasone dipropionate or any excipients in the formulation, and in patients with active untreated nasal infections unless a physician advises otherwise.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Beclometasone Dipropionate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT